Literature DB >> 18509144

Cardiovascular disease in diabetes.

Zachary T Bloomgarden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509144     DOI: 10.2337/dc08-zb06

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  10 in total

1.  Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice.

Authors:  Zhimin Zhang; Jessica S Rowlan; Qian Wang; Weibin Shi
Journal:  Circ Cardiovasc Genet       Date:  2012-01-31

Review 2.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

3.  A review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus.

Authors:  Erin L St Onge; Carol Anne Motycka; Shannon A Miller
Journal:  P T       Date:  2009-07

Review 4.  Lipid control in patients with diabetes mellitus.

Authors:  D John Betteridge
Journal:  Nat Rev Cardiol       Date:  2011-03-15       Impact factor: 32.419

5.  Ldlr-Deficient Mice with an Atherosclerosis-Resistant Background Develop Severe Hyperglycemia and Type 2 Diabetes on a Western-Type Diet.

Authors:  Weibin Shi; Jing Li; Kelly Bao; Mei-Hua Chen; Zhenqi Liu
Journal:  Biomedicines       Date:  2022-06-16

6.  Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.

Authors:  Manabu Ogita; Katsumi Miyauchi; Tadashi Miyazaki; Ryo Naito; Hirokazu Konishi; Shuta Tsuboi; Tomotaka Dohi; Takatoshi Kasai; Takayuki Yokoyama; Shinya Okazaki; Takeshi Kurata; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2013-03-21       Impact factor: 2.037

7.  Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.

Authors:  Jing Li; Qian Wang; Weidong Chai; Mei-Hua Chen; Zhenqi Liu; Weibin Shi
Journal:  Cardiovasc Diabetol       Date:  2011-12-28       Impact factor: 9.951

8.  Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains.

Authors:  Shuiping Liu; Jing Li; Mei-Hua Chen; Zhenqi Liu; Weibin Shi
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

9.  Development of a Complex Intervention for Effective Management of Type 2 Diabetes in a Developing Country.

Authors:  Tigestu Alemu Desse; Kevin Mc Namara; Helen Yifter; Elizabeth Manias
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

10.  The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus.

Authors:  Xingguang Zhang; Xiuping Xu; Xiumin Jiao; Jinxiao Wu; Shujing Zhou; Xiaofeng Lv
Journal:  J Diabetes Res       Date:  2013-07-07       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.